At the Cambridge Corporate University, we fully recognize the international pharmaceutical industry's responsibility in fighting the COVID-19 Pandemic. We also envision the essential role of our (MBA-PIM) students and graduates who are members and leaders of top-ranking pharmaceutical companies worldwide: said Prof. El-Shazly, the Chair of the Board of Trustees andProfessor of Strategic Planning and Change Management at the Cambridge Corporate University.
In the view of the unfortunate developments, the vast increase in the number of infected cases and mortality rate attached to the fast spread of the Coronavirus (Covid19) Pandemic, theAcademic Committee with the Health Care Institute(HCI) at the Cambridge Corporate University approved the obligatory offering of the Infection Control Management COVID19(ICM PIM900)Module effective April 1, 2020.
The COVID19 (ICM PIM900) Module will be offered as part of the MBA with major in thePharmaceutical Industry Management (MBA-PIM) program at the university. The Module will also be offered as an independent online course which will accept registration soon: statedDr.K.Bourget, the CCU Registrar.
At the Cambridge Corporate University, we fully recognize the international pharmaceutical industry's responsibility in fighting the COVID-19 Pandemic. We also envision the essential role of our (MBA-PIM) students and graduates who are members and leaders of top-ranking pharmaceutical companies worldwide: said Prof. El-Shazly, the Chair of the Board of Trustees andProfessor of Strategic Planning and Change Management at the Cambridge Corporate University.
In the view of the unfortunate developments, the vast increase in the number of infected cases and mortality rate attached to the fast spread of the Coronavirus (Covid19) Pandemic, theAcademic Committee with the Health Care Institute(HCI) at the Cambridge Corporate University approved the obligatory offering of the Infection Control Management COVID19(ICM-PIM900)Module effective April 1, 2020.
The COVID19 (ICM-PIM900) Module will be offered as part of the MBA with major in thePharmaceutical Industry Management (MBA-PIM) program at the university. The Module will also be offered as an independent online course which will accept registration soon: statedDr.K.Bourget, the CCU Registrar.
Module Description
Infection control is an essential component of the quality parameters of health care, patient, and public safety. It becomes a necessity to supply the world with highly qualified & well-trained infection control staff responsible for maintaining the lowest possible rate of infection during these difficult times.
Via educating participants about the implementation of the appropriate anti-COVID19 policies including, public safety procedures, safe practice, surveillance policies, and outbreaks containing strategies based on the latest studies, publications, field experiences, and results, we aim at equipping the world with a new generation of the antiCOVID professionals graduated from CCU.The Module aims to develop the knowledge and foundation skills necessary for a person involved in the infection control, planning, and management units within the international pharmaceutical industry and healthcare sector.
Infection control is an essential component of the quality parameters of health care, patient, and public safety. It becomes a necessity to supply the world with highly qualified & well-trained infection control staff responsible for maintaining the lowest possible rate of infection during these difficult times.
Via educating participants about the implementation of the appropriate anti-COVID19 policies including, public safety procedures, safe practice, surveillance policies, and outbreaks containing strategies based on the latest studies, publications, field experiences, and results, we aim at equipping the world with a new generation of the antiCOVID professionals graduated from CCU.The Module aims to develop the knowledge and foundation skills necessary for a person involved in the infection control, planning, and management units within the international pharmaceutical industry and healthcare sector.
Given the current COVID19 Pandemic development, the need to graduate students equipped with the required knowledge and skills in the field of infection control is imminent, particularly those who are well informed about the state of the art knowledge and practice directly focus on theCOVID19 Pandemic.
Given the current COVID19 Pandemic development, the need to graduate students equipped with the required knowledge and skills in the field of infection control is imminent, particularly those who are well informed about the state of the art knowledge and practice directly focus on theCOVID19 Pandemic.
Learning outcomes include
Module Description
1. Developing a sound approach to the understanding of the prevention and control strategies for healthcare professionals as well as for public entities.
2. Learning the best available methodologies in developing the COVID19 surveillance program, including knowledge of data collection, analysis, and development of action plans for governmental and healthcare entities.
3. Best practice outbreaks control by studying the current dominant cases of COVID-19 in China,Italy, the USA, and Switzerland and examining the efficiency of the control and prevention procedures.
4. Introducing the COVID19 Six Links Control Strategy (SLCS) developed by a group of talented Cambridge Corporate University scholars.
5. Providing foundation about the technical aspects of hospital hygiene, including ventilation, disinfection, and sterilization
1. Developing a sound approach to the understanding of the prevention and control strategies for healthcare professionals as well as for public entities.
2. Learning the best available methodologies in developing the COVID19 surveillance program, including knowledge of data collection, analysis, and development of action plans for governmental and healthcare entities.
3. Best practice outbreaks control by studying the current dominant cases of COVID-19 in China,Italy, the USA, and Switzerland and examining the efficiency of the control and prevention procedures.
4. Introducing the COVID19 Six Links Control Strategy (SLCS) developed by a group of talented Cambridge Corporate University scholars.
5. Providing foundation about the technical aspects of hospital hygiene, including ventilation, disinfection, and sterilization
To learn more about the MBA-PIM Program at the Cambridge Corporate University, to receive the program brochure, or apply for the program, please visit the program portal at :
http://cambridgecu.ch/mba-pim/
Call the CCU admission line at +41415004674
or write to Professor K.Bourget via:
registrar@cambridgecu.ch
To learn more about the MBA-PIM Program at the Cambridge Corporate University, to receive the program brochure, or apply for the program, please visit the program portal at :
https://www.cambridgecu.ch/.../MBA-Pharmaceutical-Industry...
Call the CCU admission line at +41415004674
or write to Professor K.Bourget via:
registrar@cambridgecu.ch
Cambridge Corporate University
Seeburgstrasse 20, 6006 Lucerne
Switzerland
Site Map Jobs Policies Trademarks Investors relations contact us Copyright
All rights reserved © 2021 By the President & Fellows of the Cambridge Corporate University